100 related articles for article (PubMed ID: 19282793)
1. 99mTc-methionine scintimammography in the evaluation of breast cancer.
Sharma R; Tripathi M; Panwar P; Chuttani K; Jaimini A; Maitra S; Chopra MK; Sawroop K; Shukla G; Mondal A; Mishra A
Nucl Med Commun; 2009 May; 30(5):338-42. PubMed ID: 19282793
[TBL] [Abstract][Full Text] [Related]
2. Technetium-99m-MIBI scintimammography in palpable and nonpalpable breast lesions.
Mekhmandarov S; Sandbank J; Cohen M; Lelcuk S; Lubin E
J Nucl Med; 1998 Jan; 39(1):86-91. PubMed ID: 9443742
[TBL] [Abstract][Full Text] [Related]
3. The role of Tc-99m methoxyisobutylisonitrile scintimammography as compared to mammography in evaluating palpable breast masses of Taiwanese women.
Sun SS; Hsieh JF; Tsai SC; Ho YJ; Lee JK; Kao CH
Anticancer Res; 2000; 20(3B):2133-6. PubMed ID: 10928166
[TBL] [Abstract][Full Text] [Related]
4. Role of technetium tetrofosmin scintimammography in the diagnosis of malignant breast masses and axillary lymph node involvement: a comparative study with mammography and histopathology.
Ortapamuk H; Ozmen MM; Ibis S; Naldöken S; Aksoy F
Eur J Surg; 1999 Dec; 165(12):1147-53. PubMed ID: 10636548
[TBL] [Abstract][Full Text] [Related]
5. (99M)Technetium-sestamibi scintimammography in non-palpable breast lesions found on screening X-ray mammography.
Gommans GM; van der Zant FM; van Dongen A; Boer RO; Teule GJ; de Waard JW
Eur J Surg Oncol; 2007 Feb; 33(1):23-7. PubMed ID: 17126524
[TBL] [Abstract][Full Text] [Related]
6. Benign versus malignant breast disease: comparison of contrast-enhanced MR imaging and Tc-99m tetrofosmin scintimammography.
Fenlon HM; Phelan NC; O'Sullivan P; Tierney S; Gorey T; Ennis JT
Radiology; 1997 Oct; 205(1):214-20. PubMed ID: 9314988
[TBL] [Abstract][Full Text] [Related]
7. 99mTc-MIBI and 99mTc-MDP scintimammography for detecting breast carcinoma.
Chen S; Liu W; Mao Y; Zhu W; Yao Z; Sun X; Xiu Y; Yin Y; Chen J
Chin Med J (Engl); 2000 May; 113(5):400-3. PubMed ID: 11776092
[TBL] [Abstract][Full Text] [Related]
8. Tc-99m tetrofosmin scintigraphy as an adjunct to plain-film mammography in palpable breast lesions.
Fenlon HM; Phelan N; Tierney S; Gorey T; Ennis JT
Clin Radiol; 1998 Jan; 53(1):17-24. PubMed ID: 9464430
[TBL] [Abstract][Full Text] [Related]
9. Technetium-99m-sestamibi scintimammography of breast lesions: clinical and pathological follow-up.
Khalkhali I; Cutrone J; Mena I; Diggles L; Venegas R; Vargas H; Jackson B; Klein S
J Nucl Med; 1995 Oct; 36(10):1784-9. PubMed ID: 7562043
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic accuracy of Tc-99m-MIBI for breast carcinoma in correlation with mammography and sonography.
Habib S; Maseeh-uz-Zaman ; Hameed A; Niaz K; Hashmi H; Kamal S
J Coll Physicians Surg Pak; 2009 Oct; 19(10):622-6. PubMed ID: 19811712
[TBL] [Abstract][Full Text] [Related]
11. [99m Tc-MIBI scintigraphy compared to mammography in the diagnosis of breast cancer in dense, operated and young women breasts].
Mulero F; Nicolás F; Castellón MI; Fuentes T; de la Cruz P; Roca V; Abad L; Nuño de La Rosa JA
Rev Esp Med Nucl; 2000 Sep; 19(5):344-9. PubMed ID: 11062110
[TBL] [Abstract][Full Text] [Related]
12. Comparative value of 99mTc-sestamibi scintimammography and sonography in the diagnostic workup of breast masses.
Klaus AJ; Klingensmith WC; Parker SH; Stavros AT; Sutherland JD; Aldrete KD
AJR Am J Roentgenol; 2000 Jun; 174(6):1779-83. PubMed ID: 10845522
[TBL] [Abstract][Full Text] [Related]
13. Role of 99mTc-MIBI scintimammography and X-ray mammography in the diagnosis of locoregional recurrence of breast cancer.
Usmani S; Niaz K; Maseeh-Uz-Zaman ; Kamal S; Niyaz K; Mehboob J; Hashmi A; Habib S; Hashmi H
J Pak Med Assoc; 2007 Apr; 57(4):172-5. PubMed ID: 17489522
[TBL] [Abstract][Full Text] [Related]
14. Functional breast imaging with Tc 99m Mibi for detection of primary breast lesion and axillary lymph node metastases.
Usmani S; Khan HA; Javed A; Al Mohannadi S; Al Huda FA; Al Shammary I
Gulf J Oncolog; 2008 Jul; (4):52-7. PubMed ID: 20084776
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic value of 99mTc MIBI scintimammography in patients with breast lesions.
Yildiz A; Colak T; Güngör F; Ozuğur S; Boz A; Tunçdemir F; Akaydin M
Rev Esp Med Nucl; 2001 Jun; 20(4):276-81. PubMed ID: 11440709
[TBL] [Abstract][Full Text] [Related]
16. The role of technetium-99m methoxyisobutylisonitrile scintimammography in diagnosis of breast cancer in patients with mammographically dense breasts.
Sun SS; Hsieh JF; Tsai SC; Ho YJ; Kao CH
Anticancer Res; 2000; 20(5C):3755-8. PubMed ID: 11268450
[TBL] [Abstract][Full Text] [Related]
17. Comparison of accuracy of scintimammography and X-ray mammography in the diagnosis of primary breast cancer in patients selected for surgical biopsy.
Cwikla JB; Buscombe JR; Kelleher SM; Parbhoo SP; Thakrar DS; Hinton J; Deery AR; Crow J; Hilson AJ
Clin Radiol; 1998 Apr; 53(4):274-80. PubMed ID: 9585043
[TBL] [Abstract][Full Text] [Related]
18. Technetium-99m-sestamibi prone scintimammography to detect primary breast cancer and axillary lymph node involvement.
Taillefer R; Robidoux A; Lambert R; Turpin S; Laperrière J
J Nucl Med; 1995 Oct; 36(10):1758-65. PubMed ID: 7562039
[TBL] [Abstract][Full Text] [Related]
19. 99m Tc-sestamibi scintimammography in detection of recurrent breast cancer.
Rajkovaca Z; Vuleta G; Matavulj A; Kovacević P; Ponorac N
Bosn J Basic Med Sci; 2007 Aug; 7(3):256-60. PubMed ID: 17848153
[TBL] [Abstract][Full Text] [Related]
20. Mammography and 99mTc-MIBI scintimammography in suspected breast cancer.
Prats E; Aisa F; Abós MD; Villavieja L; García-López F; Asenjo MJ; Razola P; Banzo J
J Nucl Med; 1999 Feb; 40(2):296-301. PubMed ID: 10025838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]